Guru Subramanian Guru Murthy

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Guru Subramanian Guru Murthy

Dec 23, 2024, 11:55 | Drugs

Talha Badar: Venetoclax and Azacitidine for elderly AML ineligible for intensive Induction

Talha Badar shared on X: “Brief overview of venetoclax+azacitidine for elderly AML ineligible for intensive…

Nov 7, 2024, 15:22 | Blog

Talha Badar: Prognostic impact of ‘multi-hit’ versus ‘single-hit’ TP53 alteration in patients with AML

Talha Badar posted on X about recent paper by him as first author, titled "Prognostic…

Jul 26, 2024, 00:17 | Insight

Anand Patel: Analysis of intensive chemotherapy in CBF-AML

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…

Jul 9, 2024, 01:37 | Blog

Anand Patel: Our recent article on accelerated/blast-phase MPNs in Blood Advances

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…

All: 4 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023